Haemonetics 3rd Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/3/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
- Analysis-Excommunications show a Pope Leo unafraid of making firm decisions
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Canaccord Starts Infleqtion, Inc (INFQ) at Buy
- Jersey Mike's Subs files for IPO on NYSE under ticker JMKE
- AXT-Tongmei signs 3-year wafer supply deal with Coherent
Haemonetics (HAE) Tops Q3 EPS by 11c
February 8, 2022 6:07 AM ESTHaemonetics (NYSE: HAE) reported Q3 EPS of $0.84, $0.11 better than the analyst estimate of $0.73. Revenue for the quarter came in at $260 million versus the consensus estimate of $266.94 million.
GUIDANCE:
Haemonetics sees FY2022 EPS of $2.45-$2.55, versus the consensus of $2.53.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
... More